The DAYANA study group: Bichat Claude Bernard Hospital and

The DAYANA study group: Bichat Claude Bernard Hospital and Université Paris Diderot (Paris,
France) – R. Landman, G. Peytavin, C. Charpentier; Faculty of Medicine and Biomedical sciences,
University of Yaoundé 1 and Central Hospital (Yaoundé, Cameroon) – S. Koulla-Shiro, M. Ngolle, C.
Kouanfack, B. Ymele, O. Elad; Fann Hospital (Dakar, Senegal) – P. S. Sow, M. B. Diallo, A. Ouattara,
A. Thiam, B. Ndiaye, M. B. Koita Fall, C. Essomba, H. Diop, F. Ngom Gueye, A. Sock, S. Legac, E.
Simen, M. Maynart; Department of Infectious Diseases, CHU Montpellier (Montpellier, France) – V. Le
Moing, S. Eymard-Duvernay, C. Toure Kane; Institut de Médecine et d’Epidémiologie Appliquée
(Paris, France) – A. Benalycherif; UMI 233, Institut de Recherche pour le Développement, Université
Montpellier 1 (Montpellier, France) – A. Aghokeng, E. Delaporte; Department of Infectious Diseases,
Saint-Antoine Hospital, and Université Pierre et Marie Curie (Paris, France) – P. M. Girard.